»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
°³¿ä
ÈäºÎ¿Ü°ú ½ÃÀåÀº 2023-2028³â¿¡ 181¾ï 3,638¸¸ ´Þ·¯, ¿¹Ãø ±â°£ Áß CAGRÀº 9.04%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
ÈäºÎ¿Ü°ú ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¡¤¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» Á¦°øÇÕ´Ï´Ù.
ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀº È£Èí±âÁúȯÀÇ À¯º´·ü »ó½Â, Àúħ½À ÈäºÎ ½Ã¼úÀÇ ¼ö¿ä Áõ°¡, °í·ÉÀÚ Àα¸ÀÇ Áõ°¡°¡ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁسâ
2023³â
Á¾·á³â
2028³â
¿¹Ãø ±â°£
2024-2028³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â´ëºñ 2024³â
8.33%
CAGR
9.04%
ÁõºÐ¾×
181¾ï 3,638¸¸ ´Þ·¯
º» Á¶»ç¿¡¼´Â ÇâÈÄ ¼ö³â°£ ÈäºÎ¿Ü°ú ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿äÀÎÀÇ Çϳª·Î ¿ø°ÝÀÇ·á¿Í ¿ø°Ý ¸ð´ÏÅ͸µÀÇ ºÎ»óÀ» µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÈäºÎ¿Ü°ú¿¡¼ ÀÇ·á ÀÎÇÁ¶ó °³¼±À» À§ÇÑ ÅõÀÚ Áõ°¡ ¹× ¿¬±¸°³¹ß Ȱµ¿ÀÇ È°¹ßȵµ ½ÃÀåÀÇ Å« ¼ö¿ä·Î ¿¬°áµË´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå ±¸µµ
Á¦3Àå ½ÃÀå ±Ô¸ð ÆÄ¾Ç
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð 2023³â
½ÃÀåÀÇ Àü¸Á 2023-2028³â
Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¼¼°èÀÇ ÈäºÎ¿Ü°ú ½ÃÀå 2018-2022³â
ÃÖÁ¾»ç¿ëÀÚº° ºÎ¹® ºÐ¼® 2018-2022³â
Á¦Ç°º° ºÎ¹® ºÐ¼® 2018-2022³â
Áö¿ªº° ºÎ¹® ºÐ¼® 2018-2022³â
±¹°¡º° ºÎ¹® ºÐ¼® 2018-2022³â
Á¦5Àå Five forces ºÐ¼®
Five Forces ¿ä¾à
±¸¸ÅÀÚÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀïÀÇ À§Çù
½ÃÀå ÇöȲ
Á¦6Àå ½ÃÀå ¼¼ºÐÈ : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ºÎ¹®
ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
º´¿ø : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
¿Ü·¡ ¼ö¼ú ¼¾ÅÍ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
Àü¹® Ŭ¸®´Ð : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
½ÃÀå ±âȸ : ÃÖÁ¾»ç¿ëÀÚº°
Á¦7Àå ½ÃÀå ¼¼ºÐÈ : Á¦Ç°º°
½ÃÀå ºÎ¹®
ºñ±³ : Á¦Ç°º°
CRM ¹× ½ÉÀå º¸Á¶ ±â±â : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
½ÉÀåÆÇ¸· ¼öº¹ ¹× ±³È¯ ±â±â : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
½ÉÆó ±â±â : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
½ÉÀå °á¼Õ Æó¼â ±â±â : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
±âŸ ÈäºÎ¿Ü°ú µð¹ÙÀ̽º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
½ÃÀå ±âȸ : Á¦Ç°º°
Á¦8Àå °í°´ »óȲ
Á¦9Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
¼¼°èÀÇ ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦10Àå ÃËÁø¿äÀÎ, °úÁ¦ ¹× µ¿Çâ
½ÃÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå µ¿Çâ
Á¦11Àå º¥´õ ±¸µµ
°³¿ä
º¥´õ ±¸µµ
È¥¶õÀÇ »óȲ
¾÷°èÀÇ ¸®½ºÅ©
Á¦12Àå º¥´õ ºÐ¼®
´ë»ó º¥´õ
º¥´õÀÇ ½ÃÀå Æ÷Áö¼Å´×
Abbott Laboratories
AbbVie Inc.
Becton Dickinson and Co.
Biosensors International Group Ltd.
BioVentrix Inc.
Boston Scientific Corp.
Cardio Medical GmbH
Edwards Lifesciences Corp.
GE Healthcare Technologies Inc.
Intuitive Surgical Inc.
Johnson and Johnson
LivaNova Plc
Medtronic Plc
Richard Wolf GmbH
Teleflex Inc.
Á¦13Àå ºÎ·Ï
KSA
Abstract
The thoracic surgery market is forecasted to grow by USD 18136.38 mn during 2023-2028, accelerating at a CAGR of 9.04% during the forecast period. The report on the thoracic surgery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of respiratory diseases, increase in demand for minimally invasive thoracic procedures, and rise in geriatric population.
Market Scope
Base Year 2023
End Year 2028
Series Year 2024-2028
Growth Momentum Accelerate
YOY 2024 8.33%
CAGR 9.04%
Incremental Value $18136.38mn
Technavio's thoracic surgery market is segmented as below:
By End-user
Hospitals
Ambulatory surgical centers
Specialty clinics
By Product
CRM and cardiac assist devices
Heart valve repair and replacement devices
Cardiopulmonary devices
Heart defect closure devices
Other thoracic surgery devices
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the emergence of telehealth and remote monitoring as one of the prime reasons driving the thoracic surgery market growth during the next few years. Also, increasing investment for improving healthcare infrastructure and increase in research and development activities in thoracic surgery will lead to sizable demand in the market.
The report on the thoracic surgery market covers the following areas:
Thoracic surgery market sizing
Thoracic surgery market forecast
Thoracic surgery market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading thoracic surgery market vendors that include Abbott Laboratories, AbbVie Inc., Becton Dickinson and Co., Biosensors International Group Ltd., BioVentrix Inc., Boston Scientific Corp., Cardio Medical GmbH, Edwards Lifesciences Corp., GE Healthcare Technologies Inc., Intuitive Surgical Inc., Johnson and Johnson, LivaNova Plc, Medtronic Plc, Richard Wolf GmbH, and Teleflex Inc.. Also, the thoracic surgery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global thoracic surgery market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global thoracic surgery market 2018 - 2022 ($ million)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospitals - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
6.4 Ambulatory surgical centers - Market size and forecast 2023-2028
Exhibit 38: Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
6.5 Specialty clinics - Market size and forecast 2023-2028
Exhibit 42: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 48: Chart on Product - Market share 2023-2028 (%)
Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
7.3 CRM and cardiac assist devices - Market size and forecast 2023-2028
Exhibit 52: Chart on CRM and cardiac assist devices - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on CRM and cardiac assist devices - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on CRM and cardiac assist devices - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on CRM and cardiac assist devices - Year-over-year growth 2023-2028 (%)
7.4 Heart valve repair and replacement devices - Market size and forecast 2023-2028
Exhibit 56: Chart on Heart valve repair and replacement devices - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Heart valve repair and replacement devices - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Heart valve repair and replacement devices - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Heart valve repair and replacement devices - Year-over-year growth 2023-2028 (%)
7.5 Cardiopulmonary devices - Market size and forecast 2023-2028
Exhibit 60: Chart on Cardiopulmonary devices - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Cardiopulmonary devices - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Cardiopulmonary devices - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Cardiopulmonary devices - Year-over-year growth 2023-2028 (%)
7.6 Heart defect closure devices - Market size and forecast 2023-2028
Exhibit 64: Chart on Heart defect closure devices - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Data Table on Heart defect closure devices - Market size and forecast 2023-2028 ($ million)
Exhibit 66: Chart on Heart defect closure devices - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Heart defect closure devices - Year-over-year growth 2023-2028 (%)
7.7 Other thoracic surgery devices - Market size and forecast 2023-2028
Exhibit 68: Chart on Other thoracic surgery devices - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Data Table on Other thoracic surgery devices - Market size and forecast 2023-2028 ($ million)
Exhibit 70: Chart on Other thoracic surgery devices - Year-over-year growth 2023-2028 (%)
Exhibit 71: Data Table on Other thoracic surgery devices - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Product
Exhibit 72: Market opportunity by Product ($ million)
Exhibit 73: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 France - Market size and forecast 2023-2028
Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 111: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 112: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 113: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 115: Market opportunity By Geographical Landscape ($ million)
Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 123: Abbott Laboratories - Overview
Exhibit 124: Abbott Laboratories - Business segments
Exhibit 125: Abbott Laboratories - Key news
Exhibit 126: Abbott Laboratories - Key offerings
Exhibit 127: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 128: AbbVie Inc. - Overview
Exhibit 129: AbbVie Inc. - Product / Service
Exhibit 130: AbbVie Inc. - Key news
Exhibit 131: AbbVie Inc. - Key offerings
12.5 Becton Dickinson and Co.
Exhibit 132: Becton Dickinson and Co. - Overview
Exhibit 133: Becton Dickinson and Co. - Business segments
Exhibit 134: Becton Dickinson and Co. - Key news
Exhibit 135: Becton Dickinson and Co. - Key offerings
Exhibit 136: Becton Dickinson and Co. - Segment focus
12.6 Biosensors International Group Ltd.
Exhibit 137: Biosensors International Group Ltd. - Overview
Exhibit 138: Biosensors International Group Ltd. - Product / Service
Exhibit 139: Biosensors International Group Ltd. - Key offerings
12.7 BioVentrix Inc.
Exhibit 140: BioVentrix Inc. - Overview
Exhibit 141: BioVentrix Inc. - Product / Service
Exhibit 142: BioVentrix Inc. - Key offerings
12.8 Boston Scientific Corp.
Exhibit 143: Boston Scientific Corp. - Overview
Exhibit 144: Boston Scientific Corp. - Business segments
Exhibit 145: Boston Scientific Corp. - Key news
Exhibit 146: Boston Scientific Corp. - Key offerings
Exhibit 147: Boston Scientific Corp. - Segment focus
12.9 Cardio Medical GmbH
Exhibit 148: Cardio Medical GmbH - Overview
Exhibit 149: Cardio Medical GmbH - Product / Service
Exhibit 150: Cardio Medical GmbH - Key offerings
12.10 Edwards Lifesciences Corp.
Exhibit 151: Edwards Lifesciences Corp. - Overview
Exhibit 152: Edwards Lifesciences Corp. - Business segments
Exhibit 153: Edwards Lifesciences Corp. - Key offerings
Exhibit 154: Edwards Lifesciences Corp. - Segment focus
12.11 GE Healthcare Technologies Inc.
Exhibit 155: GE Healthcare Technologies Inc. - Overview
Exhibit 156: GE Healthcare Technologies Inc. - Business segments
Exhibit 157: GE Healthcare Technologies Inc. - Key offerings
Exhibit 158: GE Healthcare Technologies Inc. - Segment focus
12.12 Intuitive Surgical Inc.
Exhibit 159: Intuitive Surgical Inc. - Overview
Exhibit 160: Intuitive Surgical Inc. - Product / Service
Exhibit 161: Intuitive Surgical Inc. - Key offerings
12.13 Johnson and Johnson
Exhibit 162: Johnson and Johnson - Overview
Exhibit 163: Johnson and Johnson - Business segments
Exhibit 164: Johnson and Johnson - Key news
Exhibit 165: Johnson and Johnson - Key offerings
Exhibit 166: Johnson and Johnson - Segment focus
12.14 LivaNova Plc
Exhibit 167: LivaNova Plc - Overview
Exhibit 168: LivaNova Plc - Business segments
Exhibit 169: LivaNova Plc - Key offerings
Exhibit 170: LivaNova Plc - Segment focus
12.15 Medtronic Plc
Exhibit 171: Medtronic Plc - Overview
Exhibit 172: Medtronic Plc - Business segments
Exhibit 173: Medtronic Plc - Key news
Exhibit 174: Medtronic Plc - Key offerings
Exhibit 175: Medtronic Plc - Segment focus
12.16 Richard Wolf GmbH
Exhibit 176: Richard Wolf GmbH - Overview
Exhibit 177: Richard Wolf GmbH - Product / Service
Exhibit 178: Richard Wolf GmbH - Key offerings
12.17 Teleflex Inc.
Exhibit 179: Teleflex Inc. - Overview
Exhibit 180: Teleflex Inc. - Business segments
Exhibit 181: Teleflex Inc. - Key news
Exhibit 182: Teleflex Inc. - Key offerings
Exhibit 183: Teleflex Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 184: Inclusions checklist
Exhibit 185: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 186: Currency conversion rates for US$
13.4 Research methodology
Exhibit 187: Research methodology
Exhibit 188: Validation techniques employed for market sizing
Exhibit 189: Information sources
13.5 List of abbreviations
Exhibit 190: List of abbreviations